AR084865A1 - Preparacion de desintegracion rapida, comprimido dispersable por via oral - Google Patents
Preparacion de desintegracion rapida, comprimido dispersable por via oralInfo
- Publication number
- AR084865A1 AR084865A1 ARP120100142A ARP120100142A AR084865A1 AR 084865 A1 AR084865 A1 AR 084865A1 AR P120100142 A ARP120100142 A AR P120100142A AR P120100142 A ARP120100142 A AR P120100142A AR 084865 A1 AR084865 A1 AR 084865A1
- Authority
- AR
- Argentina
- Prior art keywords
- preparation
- drug
- medicament
- oral
- granules
- Prior art date
Links
- 238000002360 preparation method Methods 0.000 title abstract 7
- 239000003814 drug Substances 0.000 abstract 7
- 239000008187 granular material Substances 0.000 abstract 4
- 229940079593 drug Drugs 0.000 abstract 3
- 239000011247 coating layer Substances 0.000 abstract 2
- 239000007884 disintegrant Substances 0.000 abstract 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 abstract 2
- 238000004519 manufacturing process Methods 0.000 abstract 2
- QLNJFJADRCOGBJ-UHFFFAOYSA-N propionamide Chemical compound CCC(N)=O QLNJFJADRCOGBJ-UHFFFAOYSA-N 0.000 abstract 2
- 229940080818 propionamide Drugs 0.000 abstract 2
- 150000005846 sugar alcohols Chemical class 0.000 abstract 2
- 208000020925 Bipolar disease Diseases 0.000 abstract 1
- 238000010521 absorption reaction Methods 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 239000008280 blood Substances 0.000 abstract 1
- 210000004369 blood Anatomy 0.000 abstract 1
- 239000002207 metabolite Substances 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 238000000465 moulding Methods 0.000 abstract 1
- 238000011321 prophylaxis Methods 0.000 abstract 1
- 238000011282 treatment Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
- A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2063—Proteins, e.g. gelatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
- A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
- C07D307/79—Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
- C07D307/81—Radicals substituted by nitrogen atoms not forming part of a nitro radical
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- General Chemical & Material Sciences (AREA)
- Neurosurgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Zoology (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Cosmetics (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2011007371 | 2011-01-17 | ||
| JP2011227333 | 2011-10-14 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR084865A1 true AR084865A1 (es) | 2013-07-10 |
Family
ID=45567081
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP120100142A AR084865A1 (es) | 2011-01-17 | 2012-01-16 | Preparacion de desintegracion rapida, comprimido dispersable por via oral |
Country Status (24)
| Country | Link |
|---|---|
| US (6) | US20120282191A1 (enExample) |
| EP (1) | EP2665465A1 (enExample) |
| JP (3) | JP5600747B2 (enExample) |
| KR (1) | KR20140014134A (enExample) |
| CN (1) | CN103429223A (enExample) |
| AR (1) | AR084865A1 (enExample) |
| AU (1) | AU2012207818B2 (enExample) |
| BR (1) | BR112013017600A2 (enExample) |
| CA (1) | CA2824430A1 (enExample) |
| CL (1) | CL2013002033A1 (enExample) |
| CO (1) | CO6791611A2 (enExample) |
| CR (1) | CR20130380A (enExample) |
| EA (1) | EA201391053A1 (enExample) |
| EC (1) | ECSP13012825A (enExample) |
| IL (1) | IL227357A0 (enExample) |
| MA (1) | MA34908B1 (enExample) |
| MX (1) | MX2013008314A (enExample) |
| PE (1) | PE20140255A1 (enExample) |
| PH (1) | PH12013501512A1 (enExample) |
| SG (1) | SG191964A1 (enExample) |
| TW (1) | TW201309347A (enExample) |
| UY (1) | UY33869A (enExample) |
| WO (1) | WO2012099260A1 (enExample) |
| ZA (1) | ZA201305567B (enExample) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8691275B2 (en) | 2011-01-28 | 2014-04-08 | Zx Pharma, Llc | Controlled-release melatonin compositions and related methods |
| US9532952B2 (en) | 2011-01-28 | 2017-01-03 | Physician's Seal, LLC | Controlled-release compositions of melatonin combined with sedative and/or analgesic ingredients |
| JP6245677B2 (ja) * | 2012-01-20 | 2017-12-13 | ニプロ株式会社 | 口腔内崩壊錠 |
| CN103989643B (zh) * | 2013-07-26 | 2018-10-30 | 武汉先路医药科技有限公司 | 含有雷美替胺和共聚维酮的片剂 |
| AU2014298130A1 (en) * | 2013-07-31 | 2016-02-11 | Intelgenx Corp. | Instantly wettable oral film dosage form without surfactant or polyalcohol |
| RU2015112640A (ru) * | 2014-02-07 | 2017-02-28 | Сайлабс Фармасьютикалс | Полностью натуральные нетоксичные сублингвальные системы доставки лекарственных средств |
| CN105853379A (zh) * | 2016-03-31 | 2016-08-17 | 北京万全德众医药生物技术有限公司 | 一种雷美替胺分散片及其制备工艺 |
| CN106389361A (zh) * | 2016-03-31 | 2017-02-15 | 北京万全德众医药生物技术有限公司 | 一种含有雷美替胺的口腔崩解片及其制备方法 |
| RU2018142019A (ru) | 2016-05-06 | 2020-06-08 | ФИЗИШН`С СИЛ, ЭлЭлСи | Валериановая композиция и соответствующие способы |
| CN106038502A (zh) * | 2016-07-01 | 2016-10-26 | 北京万全德众医药生物技术有限公司 | 一种雷美替胺口崩片及其制备方法 |
| US20210113456A1 (en) * | 2017-07-13 | 2021-04-22 | Maxinase Life Sciences Limited | Pharmaceutical compositions of ramelteon and methods of use thereof |
| FI3787596T3 (fi) | 2018-05-02 | 2025-09-29 | Ferring Bv | Parannettuja farmaseuttisia formulaatioita |
| JP7552146B2 (ja) * | 2019-08-28 | 2024-09-18 | 小野薬品工業株式会社 | イバブラジンを含有する錠剤 |
| CN113243444A (zh) * | 2020-02-13 | 2021-08-13 | 罗盖特公司 | 作为口香糖中的填充剂的多孔淀粉 |
| JP7611556B2 (ja) * | 2020-05-28 | 2025-01-10 | 日医工株式会社 | 服用性、安定性等に優れた医薬組成物 |
| CN115778925A (zh) * | 2022-12-26 | 2023-03-14 | 湖北广济医药科技有限公司 | 一种雷美替胺口溶膜剂及其制备方法 |
Family Cites Families (32)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2884153B2 (ja) * | 1996-03-08 | 1999-04-19 | 武田薬品工業株式会社 | 三環性化合物、その製造法および剤 |
| US6034239A (en) | 1996-03-08 | 2000-03-07 | Takeda Chemical Industries, Ltd. | Tricyclic compounds, their production and use |
| AU733032C (en) | 1996-06-14 | 2002-01-03 | Kyowa Hakko Kirin Co., Ltd. | Intraorally rapidly disintegrable tablet |
| JP3460538B2 (ja) | 1997-10-08 | 2003-10-27 | 救急薬品工業株式会社 | 速溶性フィルム製剤 |
| EP1736144B1 (en) * | 1998-05-18 | 2015-11-11 | Takeda Pharmaceutical Company Limited | Orally disintegrable tablets |
| WO2000047233A1 (fr) | 1999-02-15 | 2000-08-17 | Sumitomo Pharmaceuticals Co., Ltd. | Comprimes se desintegrant rapidement dans la cavite buccale |
| US6663883B1 (en) | 1999-08-26 | 2003-12-16 | Takeda Chemical Industries, Ltd. | Matrix adhering to nasal mucosa |
| WO2001076565A1 (fr) | 2000-04-12 | 2001-10-18 | Banyu Pharmaceutical Co., Ltd. | Compositions et preparations se desintegrant dans la cavite buccale |
| US7008642B1 (en) * | 2001-02-12 | 2006-03-07 | Advanced Cardiovascular Systems, Inc. | Compositions for achieving a therapeutic effect in an anatomical structure and methods of using the same |
| US20050202082A1 (en) * | 2001-09-28 | 2005-09-15 | Tsuneyuki Hibino | Press-coated molded article undergoing quick disintegration |
| FR2834890B1 (fr) | 2002-01-23 | 2004-02-27 | Servier Lab | Composition pharmaceutique orodispersible d'agomelatine |
| US20040161459A1 (en) * | 2002-12-31 | 2004-08-19 | Ngoc Do | Fast-dissolve tablet technology |
| WO2008127609A1 (en) * | 2007-04-11 | 2008-10-23 | Mccarty John A | Melatonin tablet and methods of preparation and use |
| WO2005063240A1 (en) * | 2003-12-22 | 2005-07-14 | The Brigham And Women's Hospital, Inc. | Methods and compositions for treatment of hypertension |
| WO2006107019A1 (ja) * | 2005-04-04 | 2006-10-12 | Takeda Pharmaceutical Company Limited | うつ病または不安神経症の予防または治療剤 |
| WO2007010173A1 (en) * | 2005-07-18 | 2007-01-25 | Colin Lawrence Amess | Electrostatic air filter |
| PE20070698A1 (es) * | 2005-11-14 | 2007-08-17 | Teijin Pharma Ltd | Comprimido de disgregacion rapida intraoral que contiene hidrocloruro de ambroxol |
| FR2894475B1 (fr) * | 2005-12-14 | 2008-05-16 | Servier Lab | Composition pharmaceutique orodispersible pour administra- -tion oromucosale ou sublinguale d'agomelatine |
| WO2007074856A1 (ja) * | 2005-12-28 | 2007-07-05 | Takeda Pharmaceutical Company Limited | 口腔内崩壊性固形製剤の製造法 |
| WO2007137227A1 (en) | 2006-05-22 | 2007-11-29 | Vanda Pharmaceuticals, Inc. | Treatment for depressive disorders |
| US7797869B2 (en) * | 2006-07-10 | 2010-09-21 | Tollis David R | Multi-section display and utility stanchion |
| WO2008083204A2 (en) * | 2006-12-28 | 2008-07-10 | Braincells, Inc. | Modulation of neurogenesis by melatoninergic ligands |
| US8778392B2 (en) | 2007-03-13 | 2014-07-15 | Dainippon Sumitomo Pharma Co., Ltd. | Oral disintegrating tablet |
| WO2009060318A2 (en) * | 2007-07-12 | 2009-05-14 | Teva Pharmaceutical Industries Ltd. | Polymorphic forms of ramelteon and processes for preparation thereof |
| JP2009114113A (ja) * | 2007-11-06 | 2009-05-28 | Nipro Corp | 口腔内崩壊錠及びその製造方法 |
| JP2009136240A (ja) | 2007-12-10 | 2009-06-25 | Lion Corp | チューインガム組成物 |
| EP2299981A4 (en) | 2008-06-11 | 2011-06-08 | Astrazeneca Ab | SUBLINGUAL COMPOSITIONS WITH (2S) - (4E) -N-METHYL-5- (3- (5-ISOPROPOXYPYRIDINE) YL) -4-PENTEN-2-AMINE |
| US7833819B2 (en) * | 2008-07-23 | 2010-11-16 | Aptina Imaging Corporation | Method and apparatus for decreasing storage node parasitic charge in active pixel image sensors |
| WO2010074753A1 (en) * | 2008-12-23 | 2010-07-01 | Map Pharmaceuticals, Inc. | Inhalation devices and related methods for administration of sedative hypnotic compounds |
| JP2011007371A (ja) | 2009-06-23 | 2011-01-13 | Sanyo Electric Co Ltd | 空気調和機 |
| JP5513936B2 (ja) * | 2010-03-10 | 2014-06-04 | 全星薬品工業株式会社 | 口腔内崩壊製剤 |
| JP5523913B2 (ja) | 2010-04-21 | 2014-06-18 | スタンレー電気株式会社 | 光源装置および照明装置 |
-
2012
- 2012-01-16 UY UY0001033869A patent/UY33869A/es not_active Application Discontinuation
- 2012-01-16 MA MA36182A patent/MA34908B1/fr unknown
- 2012-01-16 EP EP12702894.2A patent/EP2665465A1/en not_active Withdrawn
- 2012-01-16 JP JP2012535507A patent/JP5600747B2/ja not_active Expired - Fee Related
- 2012-01-16 WO PCT/JP2012/051279 patent/WO2012099260A1/en not_active Ceased
- 2012-01-16 AU AU2012207818A patent/AU2012207818B2/en not_active Ceased
- 2012-01-16 MX MX2013008314A patent/MX2013008314A/es unknown
- 2012-01-16 PH PH1/2013/501512A patent/PH12013501512A1/en unknown
- 2012-01-16 EA EA201391053A patent/EA201391053A1/ru unknown
- 2012-01-16 CA CA2824430A patent/CA2824430A1/en not_active Abandoned
- 2012-01-16 US US13/261,266 patent/US20120282191A1/en not_active Abandoned
- 2012-01-16 AR ARP120100142A patent/AR084865A1/es unknown
- 2012-01-16 CN CN2012800138646A patent/CN103429223A/zh active Pending
- 2012-01-16 TW TW101101549A patent/TW201309347A/zh unknown
- 2012-01-16 SG SG2013053772A patent/SG191964A1/en unknown
- 2012-01-16 KR KR1020137021442A patent/KR20140014134A/ko not_active Withdrawn
- 2012-01-16 PE PE2013001568A patent/PE20140255A1/es not_active Application Discontinuation
- 2012-01-16 BR BR112013017600A patent/BR112013017600A2/pt not_active IP Right Cessation
- 2012-10-09 US US13/647,784 patent/US8642648B2/en not_active Expired - Fee Related
- 2012-10-09 US US13/647,788 patent/US8642649B2/en not_active Expired - Fee Related
-
2013
- 2013-07-07 IL IL227357A patent/IL227357A0/en unknown
- 2013-07-12 CL CL2013002033A patent/CL2013002033A1/es unknown
- 2013-07-23 ZA ZA2013/05567A patent/ZA201305567B/en unknown
- 2013-08-07 CR CR20130380A patent/CR20130380A/es unknown
- 2013-08-13 EC ECSP13012825 patent/ECSP13012825A/es unknown
- 2013-08-16 CO CO13195977A patent/CO6791611A2/es not_active Application Discontinuation
-
2014
- 2014-01-30 US US14/168,392 patent/US20140235709A1/en not_active Abandoned
- 2014-01-30 US US14/168,400 patent/US20140235879A1/en not_active Abandoned
- 2014-07-01 JP JP2014136302A patent/JP2014198723A/ja active Pending
-
2016
- 2016-01-15 JP JP2016006663A patent/JP2016053094A/ja active Pending
- 2016-11-18 US US15/355,357 patent/US20170065553A1/en not_active Abandoned
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR084865A1 (es) | Preparacion de desintegracion rapida, comprimido dispersable por via oral | |
| NZ727975A (en) | Compositions comprising electrohydrodynamically obtained fibres for administration of specific dosages of an active substance to skin or mucosa | |
| PH12015502134A1 (en) | Mosapride sustained-release preparation for providing pharmacological and clinical effects with once-a-day administration | |
| GT200600445A (es) | Formas de presentación farmaceuticas solidas de administración oral con liberacion rapida del principio activo. | |
| MX363495B (es) | Proceso de manufacturacion de una forma de dosificacion multifasica de rapida disolucion liofilizada. | |
| MX2010001401A (es) | Productos medicos mejorados, revestidos con preparaciones farmaceuticas, la produccion de los mismos y el uso de los mismos. | |
| NZ606993A (en) | Combination pharmaceutical composition and methods of treating and preventing the infectious diseases | |
| RU2013106172A (ru) | Композиция для снятия усталости, состав и их применение | |
| JP2013541583A5 (enExample) | ||
| PE20160183A1 (es) | FORMULACION DE LIBERACION MODIFICADA DEL ACIDO (-)-(3aR,4S,7aR)-4-HIDROXI-4m-TOLILETINIL-OCTAHIDRO-INDOL-1-CARBOXILICO (AFQ056) | |
| EA201391689A1 (ru) | Система доставки лекарственного средства | |
| CO6180495A2 (es) | Formulacion de medicamento liquida | |
| ES2469240B1 (es) | Uso de un agente fotosensible capaz de producir especies reactivas de oxígeno en la preparación de un medicamento útil para la terapia fotodinámica de una enfermedad relacionada con células madre, uso "in vitro" y composición farmacéutica. | |
| AR086491A1 (es) | Composicion farmaceutica que comprende fexofenadina | |
| MX2019004736A (es) | Mini-tabletas de melatonina y metodos de fabricacion de las mismas. | |
| JP2013541582A5 (enExample) | ||
| RU2016144695A (ru) | Комплекс танната ситаглиптина | |
| MX2021001845A (es) | Un medicamento combinado que comprende fenilefrina y paracetamol. | |
| EA201301275A1 (ru) | Соединения, фармацевтические композиции и способ профилактики и лечения спаечного процесса | |
| DOP2011000267A (es) | Composicion farmaceutica oral para uso en enfermedades respiratorias | |
| WO2011126327A3 (en) | Pharmaceutical composition with controlled-release properties comprising mosapride or levodropropizine, and preparing method thereof | |
| HK1244231A1 (zh) | 使用hcg治疗慢性疼痛的方法和治疗 | |
| EA201991359A1 (ru) | Фармацевтические лекарственные формы | |
| CO2018010142A2 (es) | Proceso de preparación de fórmulas solidas de mesalazina | |
| MX2011011879A (es) | Uso de las betaxantinas y sus derivados para preparar un medicamento para el tratamiento de la prediabetes y diabetes. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |